How did BNTX's Q3 2024 forecast compare to past performance?
4/8/2025 12:41am
BioNTech (BNTX) Q3 2024's estimated EPS of $1.26 is lower than its closing price of $118.77 on September 30, 2024, indicating a potential overvaluation. The stock's recent price increase from $87.6 to $100.63 on September 10, 2024, suggests market optimism, which may not be fully supported by the earnings estimate.